Never too old: A single-institution experience of stereotactic body radiation therapy for patients 90 years and older with early stage lung cancer

Lung SBRT appears to be safe and effective in nonagenarians with stage I lung cancer. The absence of high-grade toxicities and mortality warrants its consideration as the primary curative modality in this population.